Viral Clearance and Neuroinflammation in Acute TMEV Infection Vary by Host Genetic Background

A wide range of viruses cause neurological manifestations in their hosts. Infection by neurotropic viruses as well as the resulting immune response can irreversibly disrupt the complex structural and functional architecture of the brain, depending in part on host genetic background. The interaction between host genetic background, neurological response to viral infection, and subsequent clinical manifestations remains poorly understood. In the present study, we used the genetically diverse Collaborative Cross (CC) mouse resource to better understand how differences in genetic background drive clinical signs and neuropathological manifestations of acute Theiler’s murine encephalomyelitis virus (TMEV) infection. For the first time, we characterized variations of TMEV viral tropism and load based on host genetic background, and correlated viral load with microglial/macrophage activation. For five CC strains (CC002, CC023, CC027, CC057, and CC078) infected with TMEV, we compared clinical signs, lesion distribution, microglial/macrophage response, expression, and distribution of TMEV mRNA, and identified genetic loci relevant to the early acute (4 days post-infection [dpi]) and late acute (14 dpi) timepoints. We examined brain pathology to determine possible causes of strain-specific differences in clinical signs, and found that fields CA1 and CA2 of the hippocampal formation were especially targeted by TMEV across all strains. Using Iba-1 immunolabeling, we identified and characterized strain- and timepoint-specific variation in microglial/macrophage reactivity in the hippocampal formation. Because viral clearance can influence disease outcome, we used RNA in situ hybridization to quantify viral load and TMEV mRNA distribution at both timepoints. TMEV mRNA expression was broadly distributed in the hippocampal formation at 4 dpi in all strains but varied between radiating and clustered distribution depending on the CC strain. We found a positive correlation between microglial/macrophage reactivity and TMEV mRNA expression at 4 dpi. At 14 dpi, we observed a dramatic reduction in TMEV mRNA expression, and localization to the medial portion of field CA1 and field CA2. To better understand how host genetic background can influence pathological outcomes, we identified quantitative trait loci associated with frequency of lesions in a particular brain region and with microglial/macrophage reactivity. These QTL were located near several loci of interest: lysosomal trafficking regulator (Lyst) and nidogen 1 (Nid1), and transmembrane protein 106 B (Tmem106b). Together, these results provide a novel understanding about the influences of genetic variation on the acute neuropathological and immunopathological environment and viral load, which collectively lead to variable disease outcomes. Our findings reveal possible avenues for future investigation which may lead to more effective intervention strategies and treatment regimens.

[1]  D. Threadgill,et al.  Genetic and immunological contributors to virus-induced paralysis , 2021, Brain, behavior, & immunity - health.

[2]  D. Threadgill,et al.  Resilience in Long-Term Viral Infection: Genetic Determinants and Interactions , 2021, International journal of molecular sciences.

[3]  D. Threadgill,et al.  Host genetic diversity drives variable central nervous system lesion distribution in chronic phase of Theiler’s Murine Encephalomyelitis Virus (TMEV) infection , 2021, PloS one.

[4]  D. Lambrechts,et al.  Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2 , 2021, Nature Genetics.

[5]  M. Prinz,et al.  The roles of microglia in viral encephalitis: from sensome to therapeutic targeting , 2021, Cellular & Molecular Immunology.

[6]  Tuancheng Feng,et al.  Physiological and pathological functions of TMEM106B: a gene associated with brain aging and multiple brain disorders , 2021, Acta Neuropathologica.

[7]  E. Keithley,et al.  Human Cytomegalovirus Interactions with the Basement Membrane Protein Nidogen 1 , 2020, Journal of Virology.

[8]  Gabriele Vargas,et al.  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and glial cells: Insights and perspectives , 2020, Brain, Behavior, & Immunity - Health.

[9]  James J. Cai,et al.  Antecedent presentation of neurological phenotypes in the Collaborative Cross reveals four classes with complex sex-dependencies , 2020, Scientific Reports.

[10]  D. Donati Viral infections and multiple sclerosis , 2020, Drug Discovery Today: Disease Models.

[11]  S. Agner,et al.  Neuroinflammation During RNA Viral Infections. , 2019, Annual review of immunology.

[12]  Martin T. Ferris,et al.  The Collaborative Cross: A Systems Genetics Resource for Studying Host-Pathogen Interactions , 2019, Cell Host & Microbe.

[13]  D. J. Doty,et al.  Microglial cell depletion is fatal with low level picornavirus infection of the central nervous system , 2019, Journal of NeuroVirology.

[14]  Jia Gu,et al.  Novel mutations of STXBP2 and LYST associated with adult haemophagocytic lymphohistiocytosis with Epstein-Barr virus infection: a case report , 2019, BMC Medical Genetics.

[15]  W. Löscher,et al.  Facets of Theiler’s Murine Encephalomyelitis Virus-Induced Diseases: An Update , 2019, International journal of molecular sciences.

[16]  K. Boycott,et al.  Lysosomal dysfunction in TMEM106B hypomyelinating leukodystrophy , 2018, Neurology: Genetics.

[17]  W. Löscher,et al.  Microglia have a protective role in viral encephalitis-induced seizure development and hippocampal damage , 2018, Brain, Behavior, and Immunity.

[18]  I. Rusyn,et al.  gQTL: A Web Application for QTL Analysis Using the Collaborative Cross Mouse Genetic Reference Population , 2018, G3: Genes, Genomes, Genetics.

[19]  H. Budka,et al.  Greenfield's Neuropathology - Two Volume Set , 2018 .

[20]  Honglin Luo,et al.  Enteroviral Infection: The Forgotten Link to Amyotrophic Lateral Sclerosis? , 2018, Front. Mol. Neurosci..

[21]  D. Wells,et al.  Characterisation of the pathogenic effects of the in vivo expression of an ALS-linked mutation in D-amino acid oxidase: Phenotype and loss of spinal cord motor neurons , 2017, PloS one.

[22]  G. Pijlman,et al.  Why do Individuals Differ in Viral Susceptibility? A Story Told by Model Organisms , 2017, Viruses.

[23]  D. Threadgill,et al.  Host genetic background influences diverse neurological responses to viral infection in mice , 2017, Scientific Reports.

[24]  J. Libbey,et al.  Theiler's murine encephalomyelitis virus infection of SJL/J and C57BL/6J mice: Models for multiple sclerosis and epilepsy , 2017, Journal of Neuroimmunology.

[25]  C. Bertram,et al.  The Pathologist 2.0: An Update on Digital Pathology in Veterinary Medicine , 2017, Veterinary pathology.

[26]  W. Löscher,et al.  Viral mouse models of multiple sclerosis and epilepsy: Marked differences in neuropathogenesis following infection with two naturally occurring variants of Theiler's virus BeAn strain , 2017, Neurobiology of Disease.

[27]  O. Holst,et al.  Lysosomal trafficking regulator Lyst links membrane trafficking to toll-like receptor–mediated inflammatory responses , 2017, The Journal of experimental medicine.

[28]  Alexandra M. Nicholson,et al.  What we know about TMEM106B in neurodegeneration , 2016, Acta Neuropathologica.

[29]  K. Wilcox,et al.  Neuronal Injury, Gliosis, and Glial Proliferation in Two Models of Temporal Lobe Epilepsy , 2016, Journal of neuropathology and experimental neurology.

[30]  C. Cepeda,et al.  Forebrain deletion of the dystonia protein torsinA causes dystonic-like movements and loss of striatal cholinergic neurons , 2015, eLife.

[31]  D. Cleveland,et al.  Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis , 2013, Neuron.

[32]  Rikke Riber-Hansen,et al.  Digital image analysis: a review of reproducibility, stability and basic requirements for optimal results , 2012, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[33]  R. Webster,et al.  Inflammatory Effects of Highly Pathogenic H5N1 Influenza Virus Infection in the CNS of Mice , 2012, The Journal of Neuroscience.

[34]  J. Libbey,et al.  Lack of Correlation of Central Nervous System Inflammation and Neuropathology with the Development of Seizures following Acute Virus Infection , 2011, Journal of Virology.

[35]  A. Fontanet,et al.  Identification of a Novel Neuropathogenic Theiler's Murine Encephalomyelitis Virus , 2011, Journal of Virology.

[36]  J. Libbey,et al.  Innate but not adaptive immune responses contribute to behavioral seizures following viral infection , 2010, Epilepsia.

[37]  R. Fujinami,et al.  Theiler’s virus infection chronically alters seizure susceptibility , 2009, Epilepsia.

[38]  J. Libbey,et al.  Seizures following picornavirus infection , 2008, Epilepsia.

[39]  G. Hasçelik,et al.  Investigation of HSV-1, HSV-2, CMV, HHV-6 and HHV-8 DNA by real-time PCR in surgical resection materials of epilepsy patients with mesial temporal lobe sclerosis , 2008, Journal of the Neurological Sciences.

[40]  C. Köhler Allograft inflammatory factor-1/Ionized calcium-binding adapter molecule 1 is specifically expressed by most subpopulations of macrophages and spermatids in testis , 2007, Cell and Tissue Research.

[41]  M. Buchmeier,et al.  Exacerbated Pathology of Viral Encephalitis in Mice with Central Nervous System-Specific Autoantibodies , 2007, The American Journal of Pathology.

[42]  B. Sonawane,et al.  Neurodegenerative Diseases: An Overview of Environmental Risk Factors , 2005, Environmental health perspectives.

[43]  Nengjun Yi,et al.  The Collaborative Cross, a community resource for the genetic analysis of complex traits , 2004, Nature Genetics.

[44]  M. Meagher,et al.  Chronic restraint stress during early Theiler's virus infection exacerbates the subsequent demyelinating disease in SJL mice , 2004, Journal of Neuroimmunology.

[45]  M. Cheeran,et al.  Role of Microglia in Central Nervous System Infections , 2004, Clinical Microbiology Reviews.

[46]  M. Meagher,et al.  Social stress alters the severity of acute Theiler's virus infection , 2004, Journal of Neuroimmunology.

[47]  Robert W. Williams,et al.  Genetic dissection of complex and quantitative traits: from fantasy to reality via a community effort , 2002, Mammalian Genome.

[48]  M. Meagher,et al.  The Effects of Restraint Stress on the Neuropathogenesis of Theiler's Virus Infection: I. Acute Disease , 2001, Brain, Behavior, and Immunity.

[49]  R. Fielding,et al.  A novel behavioral method to detect motoneuron disease in Wobbler mice aged three to seven days old , 1998, Brain Research.

[50]  P. Schmitz,et al.  The spectrum of antecedent infections in Guillain-Barré syndrome , 1998, Neurology.

[51]  Moses Rodriguez,et al.  CD4+ and CD8+ T Cells Make Discrete Contributions to Demyelination and Neurologic Disease in a Viral Model of Multiple Sclerosis , 1998, Journal of Virology.

[52]  S. Miller,et al.  Theiler's Murine Encephalomyelitis Virus (TMEV)-Induced Demyelination: A Model for Human Multiple Sclerosis , 1996, Methods.

[53]  H. Lipton Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination , 1975, Infection and immunity.

[54]  K. Bignall Ontogeny of levels of neural organization: the righting reflex as a model. , 1974, Experimental Neurology.

[55]  M. Wozniak,et al.  Herpes simplex virus type 1, apolipoprotein E, and cholesterol: a dangerous liaison in Alzheimer's disease and other disorders. , 2006, Progress in lipid research.